9 Jan 2020 14:30
9 January 2020
SalvaRx Group plc
("SalvaRx" or the "Company")
Cancellation of trading on AIM
Further to the Company's announcement of 20 December 2019, SalvaRx confirms that the cancellation of the admission to trading of the Company's ordinary shares on AIM will take effect from 7.00 a.m. on 10 January 2020.
The Board anticipates making a further announcement about a potential acquisition shortly which will, should this transaction proceed, involve a reverse takeover by the Company and re-listing of the Company's ordinary shares.
Enquiries
SalvaRx Group plc Denham Eke | Tel: +44 (0) 01624 639396 |
SP Angel Corporate Finance LLP Nominated Adviser and Broker Matthew Johnson / Caroline Rowe (Corporate Finance) Abigail Wayne (Corporate Broking) | Tel: +44 (0) 20 3470 0470 |
Peterhouse Corporate Finance Limited Joint Broker Lucy Williams / Duncan Vasey | Tel: +44 (0) 20 7469 0932 |